Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose-Response Impact of Glucosyl-Hesperidin (CitraPeak) on Exercise Performance, Blood Flow, Stress, Cognition, and Other Perceptual Indicators

NCT06672952 is registered in ClinicalTrials.gov with Lindenwood University as lead sponsor.

NCT NCT06672952
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06672952 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose-Response Impact of Glucosyl-Hesperidin (CitraPeak) on Exercise Performance, Blood Flow, Stress, Cognition, and Other Perceptual Indicators
Lead sponsor
Lindenwood University
Phase
Not applicable
Overall status
Recruiting
Start date
April 15, 2025
Completion date
January 1, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood flow, cognitive function, endurance exercise, exercise performance, exercise recovery, nitric oxide